Candel Therapeutics Inc (NASDAQ:CADL) concluded the trading at $12.21 on current market day with a rise of 16.62% from its closing price on previous day.
Considering stock’s 52-week price range provides that CADL hit a high price of $14.60 and saw its price falling to a low level of $1.34 during that period. Over a period of past 1-month, stock came adding 84.86% in its value.
With its current market valuation of $543.05 million, Candel Therapeutics Inc is set to declare its quarterly results in March. Analysts are in estimates of -0.23 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -1.14 for current year with estimates of that growing to -0.9 in next year.
In contrast, when we review CADL stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 50% Buy for it.
According to ratings assigned by 1 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Candel Therapeutics Inc (CADL) as a Hold, while 1 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the CADL stock which is currently positioned at 0. It further provides that stock’s current price level is 49.97% away from its 20-day simple moving average and is 54.32% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 79.56 while volatility remained at 11.35% over the past week which changes to 8.00% when measuring it over the past month. Beta is valued at -1.21, while measure of average true range or ATR is currently at 0.92.
The percentage of outstanding shares held by the insiders is 31.41% while it is 36.03% for the institutional holders. Addition of 40.67% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
